Using lactated Ringer’s solution instead of normal saline to replace lost fluids in adults admitted to the hospital for…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Low-intensity stem cell transplants, which use milder conditioning regimens, appear not to damage the lungs and may even improve…
A second clinical study to test how well BioLineRx’s motixafortide helps mobilize hematopoietic stem cells for use in gene…
Explosive synchronization in the brain, wherein a small change in the brain network causes it to sync up and undergo…
A bone marrow transplant approach that doesn’t use high-dose chemotherapy to prevent an immune response against a donor’s stem cells…
Oxbryta (voxelotor), an oral medication approved to treat sickle cell disease (SCD), prevented children’s red blood cells from…
While children with sickle cell anemia — the most common form of sickle cell disease — are vulnerable to…
Nearly 1 in 3 children and teens with sickle cell disease (SCD) reports persistent or chronic pain, according to…
A biomedical engineer at Kennesaw State University has been given a $426,000 grant to build a low-cost device helping to…
The first patient has been dosed in BEACON, a Phase 1/2 clinical trial of a transplant-based gene-editing stem cell therapy…